Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Children’s mental health services good but variable, CQC says

'Too many children and young people have a poor experience of care and some are simply unable to access timely and appropriate support', the Care Quality...Read more

EMA to restrict daclizumab use for MS

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency has recommended that provisional measures to restrict the use of...Read more

Compulsory Treatment in the Community, if so, on what basis?

A request for help from psychiatrists and all community mental health practitioners. The Dutch government is introducing new mental health legislation, which...Read more

Antidepressant adherence not related to prescriber status

There is minimal variation in adherence to antidepressant therapy between patients treated by a psychiatrist and those treated by a GP, a US study shows (J...Read more

Public concern about pregabalin prescribing and abuse

There is wide variation between clinical commissioning groups in prescribing rates of pregabalin and growing concern that prescribed treatment is being...Read more

Featured Articles

SSRI-induced severe adverse cutaneous reaction – a case report
As selective serotonin re-uptake inhibitors (SSRIs) are commonly prescribed, less common side-effects such as severe adverse cutaneous drug reactions (ACDRs) can be seen more frequently than with less frequently prescribed antidepressants. Sertraline is among the better tolerated SSRIs. Here, we describe a case of a sertraline-induced severe ACDR in a patient with depressive symptoms and cognitive impairment, with a review of recent literature on the clinical and temporal presentation of SSRI-induced ACDRs. 
Click here to view

Recurrent transient global amnesia: is there a link to familial history?
Although most episodes of transient global amnesia (TGA) are single or unique, there is a low recurrence rate. The factors associated with recurrence are uncertain. In this article, Dr Larner describes a patient with recurrent TGA and a positive family history, which prompted consideration of the possible role of genetic factors in TGA recurrence.
Click here to view

Association between antipsychotics and adverse outcomes in dementia
Prolonged use of antipsychotics continues to be a controversial subject area, especially in the older adult population due to age-related changes in pharmacokinetic and pharmacodynamics parameters. Best practice guidelines recommends that they should be used at their lowest dosage for no longer than 6–12 weeks. Here, the authors discuss the prevalence of antipsychotic use to treat the behavioural and psychological symptoms of dementia in the older adult population and the dilemma it poses.
Click here to view

Web design and marketing agency Leamington Spa